Evaluation of 11-[H-3]-tetrodotoxin use in a heterologous receptor bindingassay for PSP toxins

Citation
Gj. Doucette et al., Evaluation of 11-[H-3]-tetrodotoxin use in a heterologous receptor bindingassay for PSP toxins, TOXICON, 38(11), 2000, pp. 1465-1474
Citations number
11
Categorie Soggetti
Pharmacology & Toxicology
Journal title
TOXICON
ISSN journal
00410101 → ACNP
Volume
38
Issue
11
Year of publication
2000
Pages
1465 - 1474
Database
ISI
SICI code
0041-0101(200011)38:11<1465:EO1UIA>2.0.ZU;2-V
Abstract
This report describes the preparative scale production of 11-[H-3]-tetrodot oxin (TTX) and its evaluation as a substitute for [H-3]-saxitoxin (STX) as the radioligand in a receptor binding assay for paralytic shellfish poisoni ng (PSP) toxins. Restrictions on the world-wide distribution of [H-3]-STX i mposed by the international Chemical Weapons Convention served as the prima ry impetus for this study. We have incorporated on a preparative scale, a n onexchangeable tritium label into the TTX molecule at a specific activity o f 12.90 Ci/mmol and recovered material of high radiochemical purity (98%). The resulting 11-[H-3]TTX was found to exhibit site-specific binding charac teristics in the receptor assay (dissociation constant (K-d) = 4.77 +/- 1.5 4 nM; maximum binding (B-max) = 1.62 +/- 0.24 pmol/mg of synaptosomal prote in). The inhibition constant (K-i) for the assay was 1.46 +/- 0.28 nM STX e quiv. (n = 6), with an estimated detection limit of ca. 2-4 ng STX equiv./m l in a sample extract. Moreover, quantitative comparisons indicated that 11 -[H-3]-TTX could be used interchangeably with [H-3]-STX in the receptor ass ay for determination of PSP toxicity in shellfish and algal extracts withou t compromising assay performance. We conclude that the 11-[H-3]-TTX produce d and evaluated herein exhibits physical, chemical and biological character istics suitable not only for use in the PSP receptor binding assay, but lik ely for other applications employing [H-3]-STX as the radioligand. Publishe d by Elsevier Science Ltd.